Tony Huge

MK-677 and Enclomiphene: The Natty Plus Stack That Changed the Game

Table of Contents

If you have spent any time in the Natty Plus community, two compounds come up more than any others: MK-677 (Ibutamoren) and Enclomiphene. Together, they form what many consider the foundational Natty Plus stack — a combination that targets growth hormone and testosterone optimization simultaneously, without introducing exogenous hormones into your body.

How MK-677 Works: The Growth Hormone Secretagogue

MK-677 is a ghrelin mimetic — it binds to ghrelin receptors in the brain and stimulates the pituitary gland to release more growth hormone (GH). Unlike synthetic GH injections, MK-677 works with your body’s own production system, resulting in pulsatile GH release that more closely mirrors natural patterns.

The downstream effects are significant. Elevated GH leads to increased IGF-1 (Insulin-like Growth Factor 1), which plays a critical role in muscle protein synthesis, recovery, connective tissue repair, and even sleep quality. Many users report deeper, more restorative sleep within the first week — a benefit that compounds over time.

However, MK-677 is not without trade-offs. Its ghrelin-mimicking action increases appetite substantially, and more importantly, it can cause insulin resistance over time. This is where smart stacking becomes essential.

Managing the Insulin Problem

The insulin resistance issue is one of the most discussed topics in Natty Plus circles, and for good reason. Elevated fasting glucose and insulin levels are not something to ignore — they are metabolic red flags that need active management.

This is why many Natty Plus protocols pair MK-677 with a glucose disposal agent (GDA) like Enhanced Labs SLIN. These compounds improve insulin sensitivity and help shuttle glucose into muscle cells rather than fat storage, effectively counterbalancing MK-677’s metabolic downside.

Additional strategies include timing MK-677 doses before bed (when insulin sensitivity matters less), incorporating berberine or metformin under medical supervision, and monitoring fasting glucose through regular blood work.

Enclomiphene: Testosterone Without the Shutdown

Enclomiphene is the trans-isomer of clomiphene citrate, and it has one job: stimulate your body to produce more testosterone on its own. It works by blocking estrogen receptors in the hypothalamus, which tricks the brain into signaling for more luteinizing hormone (LH) and follicle-stimulating hormone (FSH) — the hormones that tell your testes to produce testosterone.

Unlike exogenous testosterone (TRT), enclomiphene does not suppress your natural production. In fact, it enhances it. This makes it particularly attractive for men who want higher testosterone levels but are not ready to commit to lifelong hormone replacement, or for those using it as post-cycle therapy after a mild SARM cycle.

The Synergy: Why These Two Work Together

The combination of MK-677 and enclomiphene addresses two of the most important hormonal axes for muscle growth and recovery. This is a textbook application of the Tony Huge Laws of Biochemistry Physics — optimizing two independent but synergistic pathways to create a multiplicative effect without cross-suppression.

  • GH/IGF-1 axis (MK-677) — Drives recovery, sleep quality, connective tissue health, and anabolic signaling through growth hormone pathways.
  • HPG axis (Enclomiphene) — Maintains or elevates endogenous testosterone, preserving libido, mood, strength, and muscle-building capacity.

By optimizing both systems simultaneously — without shutting down either one — users report real improvements in body composition, strength, sleep, and overall well-being. And because neither compound introduces exogenous hormones, the recovery period after cycling off is minimal compared to traditional enhancement protocols.

Blood Work Is essential

Running this stack without blood work is like driving without a dashboard. At minimum, you should be tracking: total and free testosterone, IGF-1, fasting insulin and glucose, HbA1c, liver enzymes (AST/ALT), lipid panel, and prolactin. A baseline panel before starting, a mid-cycle check at 4-6 weeks, and a post-cycle panel are the standard recommendation. For a complete breakdown, see The Complete Bloodwork Panel Guide for the Enhanced Man.

If your markers are not improving — or worse, if they are moving in the wrong direction — the protocol needs adjustment. This is the essential foundation of the Natty Plus approach: you let the numbers tell you what to keep and what to cut.

Interesting Perspectives

While the MK-677 and enclomiphene stack is a classic, its application is evolving. Some advanced protocols are exploring the use of micro-dosing principles with MK-677 to mitigate insulin resistance while still gaining the sleep and recovery benefits. The concept is to use a dose just high enough to stimulate the ghrelin receptor for pulsatile GH release, but low enough to avoid significant metabolic disruption—a direct nod to receptor saturation dynamics within the Tony Huge Laws of Biochemistry Physics.

Another emerging angle is the use of this stack as a “bridge” or foundational support during cutting phases that employ powerful tools like Semaglutide. The theory is that enclomiphene preserves testosterone (which can dip in a calorie deficit), while MK-677’s GH pulse supports muscle retention and connective tissue integrity, counteracting the catabolic risk of aggressive fat loss. This turns a simple two-compound stack into a strategic, multi-phase hormonal support system.

Furthermore, the conversation is shifting from viewing enclomiphene solely as a testosterone booster to considering its potential role in long-term hormonal resilience. By periodically stimulating the hypothalamic-pituitary-gonadal (HPG) axis without suppression, some biohackers theorize it may help maintain the sensitivity and responsiveness of this system as one ages, acting as a form of “endocrine exercise.”

Is This Stack Right for You?

The MK-677 and enclomiphene stack is best suited for men over 25 who have already dialed in their training, nutrition, and sleep fundamentals. It is not a shortcut — it is an optimization layer built on top of an already solid foundation. If your diet is inconsistent, your training is unfocused, or you are sleeping five hours a night, no stack will fix that. Start with foundational protocols like The Enhanced Man Morning Routine first.

But if you have done the work and you are looking for the next level of natural performance, this is where the Natty Plus journey begins. For a deeper dive on MK-677 alone, review the complete guide to its benefits and protocols. And if you’re weighing this against more traditional options, understand the fundamental differences between SARMs and steroids.

Citations & References

  1. Smith, R. G., et al. “Peptidomimetic regulation of growth hormone secretion.” Endocrine Reviews. 1997. (Mechanism of ghrelin receptor agonism)
  2. Copinschi, G., et al. “Prolonged oral treatment with MK-677, a novel growth hormone secretagogue, improves sleep quality in man.” Neuroendocrinology. 1997. (Sleep architecture improvements)
  3. Chapman, I. M., et al. “Stimulation of the growth hormone (GH)-insulin-like growth factor I axis by daily oral administration of a GH secretagogue (MK-677) in healthy elderly subjects.” The Journal of Clinical Endocrinology & Metabolism. 1996. (IGF-1 elevation in humans)
  4. Wieckowski, K., & Frye, R. “The use of enclomiphene citrate in the treatment of hypogonadism.” Reviews in Urology. 2013. (Clinical use for testosterone elevation)
  5. Katz, D. J., et al. “Outcomes of clomiphene citrate treatment in young hypogonadal men.” BJU International. 2012. (Efficacy of clomiphene isomers)
  6. Mauras, N., et al. “Metabolic effects of oral versus transdermal estrogen in growth hormone-treated girls with Turner syndrome.” J Clin Endocrinol Metab. 2003. (GH and insulin sensitivity interactions)
  7. Veldhuis, J. D., et al. “Differential impact of age, sex steroid hormones, and obesity on basal versus pulsatile growth hormone secretion in men as assessed in an ultrasensitive chemiluminescence assay.” J Clin Endocrinol Metab. 1995. (Pulsatile GH secretion patterns)
  8. Gianatti, E. J., & Grossmann, M. “Testosterone deficiency in men.” Australian Prescriber. 2010. (HPG axis physiology)